(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SBI ALAPHARMA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

SBI ALAPHARMA

ST13

US500000088355987

Class

10

Filing

88355987

Registration

6166804

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

32

Latest update

10/07/2025

Trademark type

Word

Nice classes

10

Filing date

03/25/2019

Registration date

10/06/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/06/2020

Last transaction

10/07/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

4

Owner type

03

Owner location

Tokyo, JP

Examiner

HOFFMAN,DAVID AARON

Law office

L70

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

SBI Holdings, Inc.

Representatives

John Mueller BAKER & HOSTETLER LLP

Technical classification

Nice Classes

Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 10

Medical diagnosis machines and apparatusmedical apparatus for detecting cancer and tumors; medical inspection and test machines and apparatus for diagnostic testing of cancer or other tissue-based diagnostic testingcytology and cell-based testing; image processing machines and apparatus for medical useimage processing apparatus capable of adjusting brightnesscontour enhancementcolor enhancement of examination/diagnosis images for use with an endoscope apparatus and a camera apparatus; imaging machines and apparatus for medical usedigital cameras for use with endoscopic machines and apparatus; light source machines and apparatus for medical useLED Lighting units used with endoscopic machines and apparatus; endoscopic machines and apparatus for medical use; therapeutic and treatment machines and apparatusa medical device to treat cancers and inflammationsto kill viruses and bacteria; surgical machines and apparatussurgical forceps; chemiluminescent light sources for use in endoscopy

Publications

History of USPTO decisions and trademark events.

32 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

10/06/2025

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

02/12/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/12/2025

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

02/12/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/12/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/12/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

10/06/2020

DP1B

1(B) BASIS DELETED; PROCEED TO REGISTRATION

09/03/2020

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

09/03/2020

IUCN

NOTICE OF ALLOWANCE CANCELLED

06/29/2020

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

06/29/2020

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

06/09/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/14/2020

PUBO

PUBLISHED FOR OPPOSITION

04/14/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/25/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/06/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/03/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/03/2020

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

02/29/2020

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

01/09/2020

GNSL

LETTER OF SUSPENSION E-MAILED

01/09/2020

CNSL

SUSPENSION LETTER WRITTEN

01/09/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/06/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/06/2020

ALIE

ASSIGNED TO LIE

01/06/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/12/2019

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

06/14/2019

GNRT

NON-FINAL ACTION E-MAILED

06/14/2019

CNRT

NON-FINAL ACTION WRITTEN

06/14/2019

DOCK

ASSIGNED TO EXAMINER

06/04/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/16/2019

NWAP

NEW APPLICATION ENTERED

03/28/2019

Continuous trademark protection

Get notified about every new filing that threatens SBI ALAPHARMA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.